BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25352052)

  • 1. Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).
    Daures M; John M; Balter CV; Simon O; Barguil Y; Missotte I; Grangeon JP; Laumond-Barny S; Noel M; Besson-Leaud L; Spasic PE; de Suremain A; Gourinat AC; Descloux E
    J Clin Immunol; 2015 Jan; 35(1):47-55. PubMed ID: 25352052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).
    Ladhani SN; Campbell H; Lucidarme J; Gray S; Parikh S; Willerton L; Clark SA; Lekshmi A; Walker A; Patel S; Bai X; Ramsay M; Borrow R
    BMC Infect Dis; 2019 Jun; 19(1):522. PubMed ID: 31200658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complement deficiencies and meningococcal disease in The Netherlands].
    Swart AG; Fijen CA; te Bulte MT; Daha MR; Dankert J; Kuijper EJ
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1147-52. PubMed ID: 8316311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian Meningococcal Surveillance Programme annual report, 2014.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine].
    Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L
    Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012.
    Säll O; Stenmark B; Glimåker M; Jacobsson S; Mölling P; Olcén P; Fredlund H
    Epidemiol Infect; 2017 Jul; 145(10):2137-2143. PubMed ID: 28478773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.
    Bröker M; Emonet S; Fazio C; Jacobsson S; Koliou M; Kuusi M; Pace D; Paragi M; Pysik A; Simões MJ; Skoczynska A; Stefanelli P; Toropainen M; Taha MK; Tzanakaki G
    Hum Vaccin Immunother; 2015; 11(9):2281-6. PubMed ID: 26036710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016.
    Meiring S; Cohen C; de Gouveia L; du Plessis M; Kularatne R; Hoosen A; Lekalakala R; Lengana S; Seetharam S; Naicker P; Quan V; Reubenson G; Tempia S; von Mollendorf C; von Gottberg A;
    Clin Infect Dis; 2019 Jul; 69(3):495-504. PubMed ID: 30351372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
    Vickers DM; Anonychuk AM; De Wals P; Demarteau N; Bauch CT
    Vaccine; 2015 Jan; 33(1):268-75. PubMed ID: 24103896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001).
    Caniça M; Dias R; Nunes B; Carvalho L; Ferreira E; The Meningococci Study Group
    J Med Microbiol; 2004 Sep; 53(Pt 9):921-925. PubMed ID: 15314201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
    Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent increase in atypical presentations of invasive meningococcal disease in France.
    Taha S; Deghmane AE; Taha MK
    BMC Infect Dis; 2024 Jun; 24(1):640. PubMed ID: 38926823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deafness, complement deficiencies and immunoglobulin status in patients with meningococcal diseases due to uncommon serogroups.
    Mayatepek E; Grauer M; Hänsch GM; Sonntag HG
    Pediatr Infect Dis J; 1993 Oct; 12(10):808-11. PubMed ID: 8284115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.